Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM) announces that it has established a manufacturing and marketing agreement with Bharat Biotech International Limited (“Bharat Biotech”) of India relating to Acambis’ ChimeriVax-JE investigational vaccine against Japanese encephalitis (“JE”).
